Hirotoshi Echizen

发表

Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem

M. Eichelbaum, H. Echizen, Hirotoshi Echizen, 1986, Clinical pharmacokinetics.

Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children

S. Ishikawa, H. Echizen, S. Nomoto, 2000, Clinical pharmacology and therapeutics.

Simultaneous High‐Performance Liquid Chromatography‐Electrochemical Detection Determination of Imipramine, Desipramine, Their 2‐Hydroxylated Metabolites, and Imipramine N‐Oxide in Human Plasma and Urine: Preliminary Application to Oxidation Pharmacogenetics

K. Chiba, T. Ishizaki, E. Koyama, 1993, Therapeutic Drug Monitoring.

An Interindividual Variability in the Sensitivity of Atrioventricular Node to Diltiazem in Patients with Paroxysmal Supraventricular Tachycardia

T Ishizaki, T. Ishizaki, H. Echizen, 1989, Journal of clinical pharmacology.

Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes

H. Echizen, H Takahashi, T Kashima, 1998, Clinical pharmacology and therapeutics.

Disposition kinetics and dynamics of nicainoprol, a new antiarrhythmic agent, in humans

K. Chiba, T. Ishizaki, H. Echizen, 1987, Clinical pharmacology and therapeutics.

Measurement of Serotonin Turnover Rate in Rat Dorsal Raphe Nucleus by In Vivo Electrochemistry

H. Echizen, C. Freed, Hirotoshi Echizen, 1984, Journal of neurochemistry.

Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone

T. Shimizu, H. Echizen, H. Tainaka, 1999, Clinical pharmacology and therapeutics.

Hemofiltrability of Histamine H2‐Receptor Antagonist, Nizatidine, and its Metabolites in Patients with Renal Failure

T. Ishizaki, H. Echizen, K. Yoshimoto, 1993, Journal of clinical pharmacology.